|
|
||||||||
The Journal of Immunology, Vol 151, Issue 10 5328-5337, Copyright © 1993 by American Association of Immunologists
ARTICLES |
PA Mathew, BA Garni-Wagner, K Land, A Takashima, E Stoneman, M Bennett and V Kumar
Laboratory of Molecular Pathology, University of Texas Southwestern Medical Center at Dallas 75235.
We have recently described a signal transducing molecule, 2B4, expressed on all NK and T cells that mediate non-MHC-restricted killing. The gene encoding this molecule was cloned and its nucleotide sequence determined. The encoded protein of 398 amino acids has a leader peptide of 18 amino acids and a transmembrane region of 24 amino acids. The predicted protein has eight N-linked glycosylation sites, suggesting that it is highly glycosylated. Comparison of 2B4 with sequences in the databanks indicates that 2B4 is a member of Ig supergene family, and it shows homology to murine and rat CD48 and human LFA-3. Northern blot analysis has shown at least three transcripts for 2B4 in adherent lymphokine-activated killer cells of several mouse strains and TCR-gamma/delta dendritic epidermal T cell lines but not in allospecific T cell clones. These three mRNA are the products of differential splicing of heterogeneous nuclear RNA. Southern blot analysis of genomic DNA from several mouse strains revealed that 2B4 belongs to a family of closely related genes. The 2B4 gene has been mapped to mouse chromosome 1 by analysis of 2B4 expression in recombinant inbred mouse strains.
This article has been cited by other articles:
![]() |
L. K. Chlewicki, C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza, and V. Kumar Molecular Basis of the Dual Functions of 2B4 (CD244) J. Immunol., June 15, 2008; 180(12): 8159 - 8167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wahle, K. H. T. Paraiso, R. D. Kendig, H. R. Lawrence, L. Chen, J. Wu, and W. G. Kerr Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell J. Immunol., December 15, 2007; 179(12): 8009 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells J. Leukoc. Biol., December 1, 2006; 80(6): 1529 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tassi and M. Colonna The Cytotoxicity Receptor CRACC (CS-1) Recruits EAT-2 and Activates the PI3K and Phospholipase C{gamma} Signaling Pathways in Human NK Cells J. Immunol., December 15, 2005; 175(12): 7996 - 8002. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aoukaty and R. Tan Role for Glycogen Synthase Kinase-3 in NK Cell Cytotoxicity and X-Linked Lymphoproliferative Disease J. Immunol., April 15, 2005; 174(8): 4551 - 4558. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Vaidya, S. E. Stepp, M. E. McNerney, J.-K. Lee, M. Bennett, K.-M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells J. Immunol., January 15, 2005; 174(2): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mooney, J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression J. Immunol., September 15, 2004; 173(6): 3953 - 3961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors Mol. Cell. Biol., June 15, 2004; 24(12): 5144 - 5156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar 2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Valdez, H. Wang, D. Seshasayee, M. van Lookeren Campagne, A. Gurney, W. P. Lee, and I. S. Grewal NTB-A, a New Activating Receptor in T Cells That Regulates Autoimmune Disease J. Biol. Chem., April 30, 2004; 279(18): 18662 - 18669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhanji and H.-S. Teh IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor Cells J. Immunol., October 1, 2003; 171(7): 3442 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, K. E. Nichols, N. J. Hare, and B. C. M. van de Weerdt Functional Requirements for Interactions Between CD84 and Src Homology 2 Domain-Containing Proteins and Their Contribution to Human T Cell Activation J. Immunol., September 1, 2003; 171(5): 2485 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, S. Bhawan, T. Majima, H. Wei, M. I. Nishimura, H. Yagita, and V. Kumar Cutting Edge: The NK Cell Receptor 2B4 Augments Antigen-Specific T Cell Cytotoxicity Through CD48 Ligation on Neighboring T Cells J. Immunol., May 15, 2003; 170(10): 4881 - 4885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Howie, S. Okamoto, S. Rietdijk, K. Clarke, N. Wang, C. Gullo, J. P. Bruggeman, S. Manning, A. J. Coyle, E. Greenfield, et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production Blood, September 26, 2002; 100(8): 2899 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Klem, P. C. Verrett, V. Kumar, and J. D. Schatzle 2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function J. Immunol., July 1, 2002; 169(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aoukaty and R. Tan Association of the X-linked Lymphoproliferative Disease Gene Product SAP/SH2D1A with 2B4, a Natural Killer Cell-activating Molecule, Is Dependent on Phosphoinositide 3-Kinase J. Biol. Chem., April 5, 2002; 277(15): 13331 - 13337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Speiser, M. Colonna, M. Ayyoub, M. Cella, M. J. Pittet, P. Batard, D. Valmori, P. Guillaume, D. Lienard, J.-C. Cerottini, et al. The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector {alpha}{beta} T Cells J. Immunol., December 1, 2001; 167(11): 6165 - 6170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chuang, P. R. Kumaresan, and P. A. Mathew 2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-{gamma} Release in Human NK Cells Involves Distinct Pathways J. Immunol., December 1, 2001; 167(11): 6210 - 6216. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bouchon, M. Cella, H. L. Grierson, J. I. Cohen, and M. Colonna Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family J. Immunol., November 15, 2001; 167(10): 5517 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakamura, J. Zarycki, J. L. Sullivan, and J. U. Jung Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome J. Immunol., September 1, 2001; 167(5): 2657 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Romero, C. Ortega, A. Palma, I. J. Molina, J. Pena, and M. Santamaria Expression of CD94 and NKG2 molecules on human CD4+ T cells in response to CD3-mediated stimulation J. Leukoc. Biol., August 1, 2001; 70(2): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bottino, M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta, et al. NTB-A, a Novel SH2D1A-associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus-infected B Cells in X-linked Lymphoproliferative Disease J. Exp. Med., July 30, 2001; 194(3): 235 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sayos, M. Martin, A. Chen, M. Simarro, D. Howie, M. Morra, P. Engel, and C. Terhorst Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP Blood, June 15, 2001; 97(12): 3867 - 3874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Czar, E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP PNAS, June 7, 2001; (2001) 131193098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chuang, H.-T. K. Pham, P. R. Kumaresan, and P. A. Mathew A Prominent Role for Activator Protein-1 in the Transcription of the Human 2B4 (CD244) Gene in NK Cells J. Immunol., May 15, 2001; 166(10): 6188 - 6195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takei, T. Ishiwata, K. Mitamura, S. Fujiwara, K. Sasaki, T. Nishi, T. Kuga, T. Ookubo, T. Horie, J. Ryu, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis Int. Immunol., April 1, 2001; 13(4): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dutz, L. Benoit, X. Wang, D. J. Demetrick, A. Junker, D. de Sa, and R. Tan Lymphocytic vasculitis in X-linked lymphoproliferative disease Blood, January 1, 2001; 97(1): 95 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sayos, K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4 Int. Immunol., December 1, 2000; 12(12): 1749 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Watzl, C. C. Stebbins, and E. O. Long Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244) J. Immunol., October 1, 2000; 165(7): 3545 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benoit, X. Wang, H. F. Pabst, J. Dutz, and R. Tan Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease J. Immunol., October 1, 2000; 165(7): 3549 - 3553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, J. H. Phillips, L. L. Lanier, and K. E. Nichols Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome J. Immunol., September 15, 2000; 165(6): 2932 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fournier, L. Chalus, I. Durand, E. Garcia, J.-J. Pin, T. Churakova, S. Patel, C. Zlot, D. Gorman, S. Zurawski, et al. FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells J. Immunol., August 1, 2000; 165(3): 1197 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J.-Y. Bonnefoy, R. Biassoni, et al. X-linked Lymphoproliferative Disease: 2B4 Molecules Displaying Inhibitory Rather Than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus-infected Cells J. Exp. Med., July 31, 2000; 192(3): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Castro, T. M. Hauser, B. G. Cocks, J. Abrams, S. Zurawski, T. Churakova, F. Zonin, D. Robinson, S. G. Tangye, G. Aversa, et al. Molecular and Functional Characterization of Mouse Signaling Lymphocytic Activation Molecule (SLAM): Differential Expression and Responsiveness in Th1 and Th2 Cells J. Immunol., December 1, 1999; 163(11): 5860 - 5870. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pende, S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, et al. Identification and Molecular Characterization of NKp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells J. Exp. Med., November 15, 1999; 190(10): 1505 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wilson, J. Charo, A. Martin-Fontecha, P. Dellabona, G. Casorati, B. J. Chambers, R. Kiessling, M.-T. Bejarano, and H.-G. Ljunggren NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86 J. Immunol., October 15, 1999; 163(8): 4207 - 4212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Wild, A. Cambiaggi, M. H. Brown, E. A. Davies, H. Ohno, T. Saito, and P. A. van der Merwe Dependence of T Cell Antigen Recognition on the Dimensions of an Accessory Receptor–Ligand Complex J. Exp. Med., July 5, 1999; 190(1): 31 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, S. Lazetic, E. Woollatt, G. R. Sutherland, L. L. Lanier, and J. H. Phillips Cutting Edge: Human 2B4, an Activating NK Cell Receptor, Recruits the Protein Tyrosine Phosphatase SHP-2 and the Adaptor Signaling Protein SAP J. Immunol., June 15, 1999; 162(12): 6981 - 6985. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Schatzle, S. Sheu, S. E. Stepp, P. A. Mathew, M. Bennett, and V. Kumar Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4 PNAS, March 30, 1999; 96(7): 3870 - 3875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Idris, K. Iizuka, H. R.C. Smith, A. A. Scalzo, and W. M. Yokoyama Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus J. Exp. Med., December 21, 1998; 188(12): 2243 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Brown, K. Boles, P. Anton van der Merwe, V. Kumar, P. A. Mathew, and A. Neil Barclay 2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 J. Exp. Med., December 7, 1998; 188(11): 2083 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Latchman, P. F. McKay, and H. Reiser Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48 J. Immunol., December 1, 1998; 161(11): 5809 - 5812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. de la Fuente, P. Pizcueta, M. Nadal, J. Bosch, and P. Engel CD84 Leukocyte Antigen Is a New Member of the Ig Superfamily Blood, September 15, 1997; 90(6): 2398 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A New Mechanism of NK Cell Cytotoxicity Activation: The CD40-CD40 Ligand Interaction J. Exp. Med., June 16, 1997; 185(12): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Punnonen, B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. d. Vries Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes J. Exp. Med., March 17, 1997; 185(6): 993 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Davis, E. A. Davies, A. N. Barclay, S. Daenke, D. L. Bodian, E. Y. Jones, D. I. Stuart, T. D. Butters, R. A. Dwek, and P. A. van der Merwe Ligand Binding by the Immunoglobulin Superfamily Recognition Molecule CD2 Is Glycosylation-independent J. Biol. Chem., January 6, 1995; 270(1): 369 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Czar, E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP PNAS, June 19, 2001; 98(13): 7449 - 7454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |